Table 2.

Relative risks (RR), with 95% confidence intervals (CIs) for clinical outcomes in new-borns in the control (group C) and treatment (group T) groups at 28 days of age.

Outcome	Group Cn = 42	Group Tn = 48	P-value	Relative risks	95% Confidence intervals
Retinopathy of prematurity	13 (31%)	6 (12.5%)	.03	0.40	0.17–0.97
Retinopathy of prematurity severity	12 = Stage I	5 = Stage I	.03	0.40	0.17–0.97
	1 = Stage II	1 = Stage II	.5	0.87	0.05–13.5
Bronchopulmonary Dysplasia	27 (64.3%)	31 (64.6%)	.97	1.00	0.74–1.37
Ductus arteriosus	19 (45.2%)	16 (33.3%)	.28	0.78	0.51–1.2
Intraventricular haemorrhage	5 (11.9%)	4 (8.3%)	.72	0.81	0.38–1.75
Sepsis	22 (52.4%)	28 (58.3%)	.72	1.11	0.76–1.6
Gastrointestinal intolerance	3 (7.1%)	7 (14.6%)	.32	1.30	0.86–2.16
Necrotizing enterocolitis	0 (0%)	1 (2.1%)	.91	2.60	0.11–61.7